Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABBV
NVO
Add up to 3 more stocks
ABBV
AbbVie Inc.
+0.01%
$261.80+0.03Delayed quote: Sep 15, 2026, 10:45 AM EDT
Market Cap
$462.55B
52W Range
$190.75 - $267.47
NVO
Novo Nordisk A/S
-2.00%
$42.58-0.87Delayed quote: Sep 15, 2026, 10:45 AM EDT
Market Cap
$189.08B
52W Range
$35.12 - $64.16
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 73.76 | 10.49 |
| Forward P/E | 18.63 | N/A |
| P/B Ratio | N/A | 5.61 |
| P/S Ratio | 7.18 | 3.70 |
| P/FCF Ratio | 25.49 | 25.38 |
| EV/EBITDA | 19.66 | 7.77 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.5% | 80.6% |
| Operating Margin | 29.3% | 43.1% |
| Net Margin | 9.8% | 35.3% |
| ROE | N/A | 53.5% |
| ROA | 4.7% | 19.9% |
| ROIC | 13.5% | 30.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.81 | 0.87 |
| Quick Ratio | 0.69 | 0.66 |
| Debt/Equity | N/A | 0.63 |
| Interest Coverage | 6.94 | 30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.7% | 4.2% |
| Payout Ratio | 192.4% | 44.3% |
| Yrs of Dividend Growth | 52 | 6 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.